2025,Yamamoto K, Takeda K, Maeda H. Retrospective Analysis of Master Protocols in Tumor-Agnostic Drug Development: Evaluation of Application to Single-Agent Therapies With ORR as the Endpoint for Approval of Oncology Drugs. Clin Transl Sci. 2025 Aug;18(8):e70313. doi: 10.1111/cts.70313.